MCHP · Microchip Technology Incorporated

The thesis

Microchip Technology's recovery in microcontrollers and analog chips is visible in reported sales, and the shares have rebounded into the report that grades it. They closed at $80.17 on 27 October 2026, 21.5% below the $102.10 52-week high. The fiscal second-quarter report, expected 4 November 2026 or 5 November 2026, settles the case: revenue of at least $1.589 billion and non-GAAP gross margin of at least 66%, the lower bounds guided on 6 August 2026, would confirm it.

The narrative is maturing: the recovery is well known, and analysts cut targets in the week of 19 October 2026 even as the shares rose. TD Cowen lowered its target to $75 from $90 on 19 October 2026. Wells Fargo lowered its to $80 from $88 and kept an Equal-Weight rating, per 19 October 2026 and 20 October 2026 news. B. Riley kept a Buy rating and lowered its target to $98 on 22 October 2026.

The prior note's $71.25 close of 14 October 2026 now stands as the recent low. The shares closed 12.5% higher on 27 October 2026, which leaves less distance between the price and the cautious targets than before the report.

Bullish and bearish views on Microchip Technology Incorporated

The bull case on Microchip Technology Incorporated (MCHP), in brief: Guidance gives a clear test. The bear case: Analysts are trimming targets into the report.

Bull case

• Guidance gives a clear test. Management guided September-quarter net sales to $1.589–$1.618 billion and non-GAAP gross margin to 66–67% on 6 August 2026. The same release guided non-GAAP earnings to $0.91–$0.95 per share.
• Channel inventory looked lean. On the 6 August 2026 call, management cited distributor inventory of 25 days and distribution sell-through up 17% sequentially. Company inventory stood at 175 days.
• Space and data-center products keep arriving. Microchip announced PIC64-HPSC spaceflight computing milestones on 27 October 2026, an LX-820 radiation-tolerant quartz oscillator on 22 October 2026, and data-center PCIe and NVMe products on 12 October 2026.
• Several targets remain well above the price. B. Riley's target of $98 (22 October 2026) sits above the $80.17 close. KeyBanc's $135 was the Street-high in aggregated results retrieved 15 October 2026.

Bear case

• Analysts are trimming targets into the report. TD Cowen cut to $75 from $90 on 19 October 2026, and Wells Fargo cut to $80 from $88 on 19 October 2026. Wells Fargo's new target is level with the 27 October 2026 close.
• The price is still well below its high. The close of $80.17 on 27 October 2026 is 21.5% under the $102.10 52-week high. The 14-day relative strength index (a momentum gauge) is 54.6, neutral.
• Acquisitions add variables to debt reduction. Management forecast on 6 August 2026 that net debt to earnings before interest, tax, depreciation and amortization (EBITDA) would fall below 2.5 times. Hailo (closed 21 September 2026) and VORAGO (9 October 2026) both carried undisclosed prices, so the funding effect is unknown until the next report.
• New announcements carry no numbers. The VORAGO deal and the space and data-center product launches of October 2026 came with no contract value or revenue contribution.
• Data-center definitions complicate comparisons. The target disclosed on 6 August 2026 combines Data Center Solutions with catalog products, while the 1 June 2026 disclosure covered Data Center Solutions alone.

Price setup

Adjusted daily closes put the shares at $80.17 on 27 October 2026. That is 21.5% below the $102.10 52-week high and 7.5% above the close three months earlier. The 14-day relative strength index is 54.6.

The 14 October 2026 close of $71.25 is the recent low in this series. The shares have since recovered to the level of the Wells Fargo target of $80. Moving-average levels are not part of this note's inputs, so none is cited.

Crowding evidence is limited. No SEC Form 4 insider filings or share issuance appear in company filings for the period. The earnings date is the main crowding variable: it falls within roughly eight days of the latest close.

Catalysts, next 30 days

• After the report — fiscal Q3 2027 guidance. The December-quarter outlook shows whether the 38.0% year-over-year growth of the June quarter is holding.

Elapsed catalysts

• 4 November 2026 or 5 November 2026 (est.) — fiscal Q2 2027 report. Microchip has not confirmed the date in the sources checked. Bullstory lists 4 November 2026 and Investor Signals lists 5 November 2026, both after the US close. Last year's report came on 6 November 2025. Revenue, gross margin and net debt to EBITDA grade the 6 August 2026 guidance. (passed 1d ago)

What would change the view

The case breaks if September-quarter revenue comes in under $1.589 billion or non-GAAP gross margin under 66%, the lower bounds guided on 6 August 2026. A net debt to EBITDA ratio at or above 2.5 times would also weaken it, since management forecast a lower figure. A December-quarter outlook that implies sequential revenue decline would show the recovery has stalled.

On price, a daily close below $71, under the 14 October 2026 close of $71.25, would erase the October rebound and put the shares below their recent low. A report that meets guidance while the shares fall would show the market is discounting a slowing recovery.

What it trades with

Microchip trades with the wider analog and microcontroller group, including Texas Instruments, NXP Semiconductors and STMicroelectronics, and with the Philadelphia Semiconductor Index. Its fiscal year ends in March, so fiscal Q2 2027 is the quarter ended September 2026. Peer reports in late October and early November are the closest read-through on industrial and automotive demand.